会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • A FAIL-SURE COMPUTER AIDED METHOD FOR ANTICOAGULANT TREATMENT
    • 抗凝血治疗失败的计算机辅助方法
    • WO0193762A9
    • 2002-03-28
    • PCT/DK0100397
    • 2001-06-08
    • MEDIMAGE APSNIELSEN PETER MICHAEL
    • NIELSEN PETER MICHAEL
    • A61B5/00G06F19/00A61B5/15
    • G06F19/3456A61B5/0022A61B5/145A61B5/14546A61B5/150022A61B5/150389A61B5/150748A61B5/150854A61B5/15113A61B5/1519A61B5/157A61B5/7275G16H10/40G16H50/70
    • The present invention relates to a method for determining a set of corresponding dose of a drug and time to take the drug. The method comprises the step of measuring a blood coagulation value at a patient and by use a first computer system determining the set of corresponding dose and time to take the drug. The determination by use of the computer system is also preferably performed at the patient. Furthermore, the present invention relates to a validation method in which data relating to the determination of the set of corresponding dose and time to take the drug is transmitted to a second computer system. By use of this second computer system a set of corresponding dose and time to take the drug is determined and this set may be validated against the set determined by the first computer system. The present invention also relates to a personal apparatus at the patient having means for taking a blood sample, means adapted to determine a set of corresponding dose and time to take the drug and means for transceiving data to and from a validation apparatus. The validation apparatus comprises means for transceiving data to and from the personal apparatus, means adapted to determining a set of corresponding dose and time to take the dose based on data received from the personal apparatus and means adapted to validate this set to the set determined by the personal apparatus.
    • 本发明涉及用于确定一组相应的药物剂量和服用该药物的时间的方法。 该方法包括测量患者的血液凝固值的步骤,并且通过使用第一计算机系统确定该组相应的服用该药物的剂量和时间。 通过使用计算机系统的确定也优选在患者处进行。 此外,本发明涉及一种验证方法,其中与确定一组相应剂量和时间服用药物有关的数据被传输到第二计算机系统。 通过使用这个第二计算机系统,确定一组相应的服药剂量和时间,并且可以根据由第一计算机系统确定的组来确认该组。 本发明还涉及患者个人装置,其具有用于采集血液样本的装置,适于确定一组相应剂量和时间来服用药物的装置以及用于向验证装置收发数据的装置。 验证装置包括用于收发数据到个人装置和从个人装置收发数据的装置,适于基于从个人装置接收到的数据确定一组相应的剂量和时间以获取剂量的装置,以及适于将该组验证为由 个人设备。
    • 2. 发明申请
    • A FAIL-SURE COMPUTER AIDED METHOD FOR ANTICOAGULANT TREATMENT
    • 一种用于抗凝治疗的失败的计算机辅助方法
    • WO0193762A2
    • 2001-12-13
    • PCT/DK0100397
    • 2001-06-08
    • MEDIMAGE APSNIELSEN PETER MICHAEL
    • NIELSEN PETER MICHAEL
    • A61B5/00G06F19/00A61B5/15
    • G06F19/3456A61B5/0022A61B5/145A61B5/14546A61B5/150022A61B5/150389A61B5/150748A61B5/150854A61B5/15113A61B5/1519A61B5/157A61B5/7275G16H10/40G16H50/70
    • The present invention relates to a method for determining a set of corresponding dose of a drug and time to take the drug. The method comprises the step of measuring a blood coagulation value at a patient and by use a first computer system determining the set of corresponding dose and time to take the drug. The determination by use of the computer system is also preferably performed at the patient. Furthermore, the present invention relates to a validation method in which data relating to the determination of the set of corresponding dose and time to take the drug is transmitted to a second computer system. By use of this second computer system a set of corresponding dose and time to take the drug is determined and this set may be validated against the set determined by the first computer system. The present invention also relates to a personal apparatus at the patient having means for taking a blood sample, means adapted to determine a set of corresponding dose and time to take the drug and means for transceiving data to and from a validation apparatus. The validation apparatus comprises means for transceiving data to and from the personal apparatus, means adapted to determining a set of corresponding dose and time to take the dose based on data received from the personal apparatus and means adapted to validate this set to the set determined by the personal apparatus.
    • 本发明涉及一种用于确定药物相应剂量的集合和服用该药物的时间的方法。 该方法包括测量患者血液凝固值的步骤,并且使用确定服用药物的相应剂量和时间的集合的第一计算机系统。 使用计算机系统的判定也优选在患者身上进行。 此外,本发明涉及一种验证方法,其中与将所述药物的相应剂量和时间的集合的确定相关的数据被发送到第二计算机系统。 通过使用该第二计算机系统,确定一组相应的服用药物的剂量和时间,并且该组可以针对由第一计算机系统确定的集合进行验证。 本发明还涉及患者具有用于服用血液样本的装置的个人装置,适于确定一组相应的剂量和时间以服用药物的装置以及用于向验证装置收发数据的装置。 验证装置包括用于向个人设备收发数据的装置,适于基于从个人装置接收的数据确定采取剂量的相应剂量和时间的集合的装置以及适于将该集合验证为由 个人设备。
    • 3. 发明申请
    • QUALITY AND SAFETY ASSURANCE OF MEDICAL APPLICATIONS
    • 医疗应用的质量和安全保证
    • WO0195253A3
    • 2002-05-10
    • PCT/DK0100396
    • 2001-06-08
    • MEDIMAGE APSNIELSEN PETER MICHAELLARSEN JAN
    • NIELSEN PETER MICHAELLARSEN JAN
    • G06N3/02
    • G06N3/02
    • The present invention relates in a broad aspect to assurance of quality and safety of medical applications determining - or suggesting - diagnosis and/or treatment. In general, such applications are according to the present invention applications which are designed to operate without assistance of a medical adviser in daily use and accordingly these applications must be supervised in some sense in order to be able to guarantee that diagnoses and/or treatments determined by these applications are not determined in a manner that patients are exposed to life threatening treatment due to malfunctioning of these applications. In the general perspective according to the present invention, treatment is suggested based on a diagnosis and a diagnosis is viewed upon as recognition of a pattern. For instance, a diagnosis is the result of recognition of a pattern of antibody substances in a sample taken from the tissue of a patient. Furthermore, the term diagnosis has been given a broad interpretation in the present content so as to include - and/or even be- determination of treatment. The philosophy behind such an approach is that the determination of a treatment is according to the present invention based on determination of a pattern. For instance in case of the prescription of a drug preventing attacks of Multiple Sclerosis, a measured blood sample may be analyzed for patterns of matter in the sample and once a pattern is recognized the treatment assigned to said pattern is the treatment suggested.
    • 本发明在广泛的方面涉及确定或建议诊断和/或治疗的医疗应用的质量和安全性的保证。 一般来说,这样的应用是根据本发明的应用程序,其被设计为在日常使用中没有医疗顾问的协助下运行,因此这些应用程序必须在某种意义上被监督,以便能够保证诊断和/或治疗确定 通过这些应用不能以由于这些应用的故障使患者面临威胁生命的治疗的方式来确定。 在根据本发明的一般观点中,基于诊断提出治疗,并且将诊断视为模式的识别。 例如,诊断是识别从患者组织中取出的样品中的抗体物质的模式的结果。 此外,术语诊断已经在本内容中被广泛解释,以包括 - 和/或甚至是确定治疗。 这种方法背后的理念是,基于确定模式,根据本发明确定治疗。 例如,在处方药物预防多发性硬化症发作的情况下,可以分析测量的血液样品中的样品中的物质模式,并且一旦识别出模式,则分配给所述模式的治疗是所建议的治疗方法。